SOTERA HEALTH COMPANY Net Income (Loss) Attributable to Noncontrolling Interest
SOTERA HEALTH COMPANY (SHC) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2024-02-27
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2022-12-31 was $0.00.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2022-09-30 was $0.00.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2023 was $0.00.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2021 was $239.00K, a 78.77% decline from fiscal 2020.
- SOTERA HEALTH COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2020 was $1.13M, a 164.94% increase from fiscal 2019.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $16.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $16.00K derived: sum of 3 quarters · filed 2024-02-27 | $239.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $16.00K derived: sum of 2 quarters · filed 2022-11-02 | $239.00K 10-Q · filed 2022-11-02 | $533.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $16.00K 10-Q · filed 2022-08-04 | $239.00K 10-Q · filed 2022-08-04 | $533.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $223.00K 10-Q · filed 2022-05-05 | $517.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.14M derived: sum of 3 quarters · filed 2023-02-28 | $1.37M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $913.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.15M derived: sum of 3 quarters · filed 2023-02-28 | $1.13M 10-K · filed 2023-02-28 |
| 2020-09-30 | $619.00K 10-Q · filed 2021-11-10 | $854.00K derived: sum of 2 quarters · filed 2021-11-10 | $832.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $235.00K 10-Q · filed 2021-08-12 | $213.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$22.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $425.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |